Berg Media

April 1, 2021

Berg taps into supercomputer to battle COVID-19 variants

News
BERG To Conduct Phase Two Trial For Treatment Of Deadly Glioblastoma Multiforme [GBM]

March 22, 2021

BERG To Conduct Phase Two Trial For Treatment Of Deadly Glioblastoma Multiforme [GBM]

Press releases
BERG Deepens Research Collaboration With AdventHealth To Advance Aging, Metabolism and Nash Research

December 15, 2020

BERG Deepens Research Collaboration With AdventHealth To Advance Aging, Metabolism and Nash Research

Press releases
BERG And AdventHealth Announce New Partnership To Decrease Mortality Rate Of COVID-19 Patients Throughout Hot Zones Across USA

November 23, 2020

BERG And AdventHealth Announce New Partnership To Decrease Mortality Rate Of COVID-19 Patients Throughout Hot Zones Across USA

Press releases

October 6, 2020

Healthcare Leaders Pioneer A New Collaboration Model To Transform The Future Of Drug Development

News

September 28, 2020

Berg Fuels Study of African-American COVID-19 Patients

News
BERG To Present Discovery/Validation Of Biomarkers Associated With Survival In Pancreatic Ductal Adenocarcinoma (PDAC) Treated With BPM 31510-IV At The European Society For Medical Oncology (ESMO) 2020 Congress

September 18, 2020

BERG To Present Discovery/Validation Of Biomarkers Associated With Survival In Pancreatic Ductal Adenocarcinoma (PDAC) Treated With BPM 31510-IV At The European Society For Medical Oncology (ESMO) 2020 Congress

Press releases
BERG’s Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population

September 8, 2020

BERG’s Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population

Press releases
BERG Announces Presentation Of Multiple Interrogative Biology Platform® And Outputs From Multiple Collaborations At AACR

June 22, 2020

BERG Announces Presentation Of Multiple Interrogative Biology Platform® And Outputs From Multiple Collaborations At AACR

Press releases

June 18, 2020

Energy Department Uses Supercomputers to Tackle COVID-19

News
BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory’s Summit Supercomputer in the Fight Against COVID-19

June 17, 2020

BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory’s Summit Supercomputer in the Fight Against COVID-19

Press releases
BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting

June 1, 2020

BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting

Press releases
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions

May 6, 2020

BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions

Press releases

May 6, 2020

Boehringer Ingelheim adds second AI partner in a month

News
BERG Named Visionary in Frost & Sullivan’s First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry

April 13, 2020

BERG Named Visionary in Frost & Sullivan’s First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry

Press releases

March 5, 2020

Transforming Drug Discovery through Artificial Intelligence.

News
BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG’s Interrogative Biology® Platform

February 27, 2020

BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG’s Interrogative Biology® Platform

Press releases

February 15, 2020

The December 2019 issue of Nature magazine describes the unique potential of the BERG platform in combining patient biology & artificial intelligence for drug and clinical development, highlights its use in the development of BPM 31510 in oncology.

News

February 14, 2020

Pod of Asclepius Podcast: BERG CEO on Value-Driven Data & AI for Pharma Innovation

News

February 14, 2020

A.I. Cancer Drugmaker Meeting with Big Pharma Companies

News
BERG Presents Data Demonstrating That BPM31510 Promotes Cytotoxic T-cell Function And Influences Checkpoint Receptor Expression Patterns To Potentially Synergize Anti-Cancer Effect In Combination With I/O Therapies

February 14, 2020

BERG Presents Data Demonstrating That BPM31510 Promotes Cytotoxic T-cell Function And Influences Checkpoint Receptor Expression Patterns To Potentially Synergize Anti-Cancer Effect In Combination With I/O Therapies

Press releases

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.